DSM Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $154M | Buy |
|
|||||
|
2018
Q4 | $139M | Buy |
|
|||||
|
2018
Q3 | $130M | Buy |
|
|||||
|
2018
Q2 | $82M | Sell |
|
|||||
|
2018
Q1 | $98.3M | Sell |
|
|||||
|
2017
Q4 | $427M | Buy |
|
|||||
|
2017
Q3 | $475M | Sell |
|
|||||
|
2017
Q2 | $532M | Buy |
|
|||||
|
2017
Q1 | $236M | Buy |
|
|||||
|
2016
Q4 | $129M | Buy |
|
|||||
|
2016
Q3 | $91.2M | Buy |
|
|||||
|
2016
Q2 | $61.3M | Sell |
|
|||||
|
2016
Q1 | $66.3M | Buy |
|
|||||
|
2015
Q4 | $98.1M | Buy |
|
|||||
|
2015
Q3 | $73.5M | Sell |
|
|||||
|
2015
Q2 | $133M | Sell |
|
|||||
|
2015
Q1 | $206M | Sell |
|
|||||
|
2014
Q4 | $212M | Sell |
|
|||||
|
2014
Q3 | $188M | Sell |
|
|||||
|
2014
Q2 | $150M | Buy |
|
|||||
|
2014
Q1 | $145M | Buy |
|
|||||
|
2013
Q4 | $99.9M | Buy |
|